| Clinical Study on the Effect of Selenium Yeast Capsule on Prognosis of Differentiated Thyroid Carcinoma (NCT04683575) | Qianfoshan Hospital | 2022-05-30 |
| Liver Transplantation for Unresectable GIST Liver Metastases (NCT04825470) | Hospital Universitario Virgen de la Arrixaca | 2022-05-01 |
| Tumor Deposits in Colorectal Cancer and Its Prognostic Value in Survival and Metastasis (NCT06884839) | Minia University | 2022-04-01 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114 (NCT05200273) | Akeso | 2022-03-15 |
| Chemokine Receptor 4 PET/CT Imaging of CXCR4-Related Diseases (NCT06690736) | Tianjin Medical University | 2022-03-01 |
| FAPI PET/CT in Various FAP-Related Disease Patients (NCT06688071) | Tianjin Medical University | 2022-03-01 |
| Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) (NCT05103358) | Aadi Bioscience, Inc. | 2022-02-15 |
| Intraoperative Laser Speckle Contrast Imaging to Assess Blood Flow During Neurosurgery (NCT05028400) | Insel Gruppe AG, University Hospital Bern | 2022-02-01 |
| Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer (NCT05021237) | University of Texas Southwestern Medical Center | 2022-02-01 |
| Cemiplimab for Secondary Angiosarcomas (NCT04873375) | Radboud University Medical Center | 2022-01-01 |
| Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric Cancer (NCT05208372) | First Hospital of China Medical University | 2022-01-01 |
| Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma (NCT05845632) | Maastricht University Medical Center | 2022-01-01 |
| Evaluation of Fast, Same-day Delivery of Palliative Radiotherapy Without a Planning CT (FAST-METS) (NCT05288608) | Amsterdam UMC, location VUmc | 2021-12-16 |
| Genomic Evolution of Metastasis in Gastric Cancer (NCT05061082) | University Medical Center Ho Chi Minh City (UMC) | 2021-10-26 |
| Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas (NCT04617457) | University of Cologne | 2021-10-10 |
| Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer (NCT05095207) | Icahn School of Medicine at Mount Sinai | 2021-09-20 |
| Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy (NCT04808466) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-09-18 |
| Trial of XRD-0394, a Kinase Inhibitor, in Combination With Palliative Radiotherapy in Advanced Cancer Patients (NCT05002140) | XRad Therapeutics Inc | 2021-08-24 |
| An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC (NCT04890522) | Sun Yat-sen University | 2021-07-01 |
| T1 Squamous Cell Carcinomas of the Lip (NCT05610293) | Maastricht University Medical Center | 2021-04-01 |
| Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer (NCT05095636) | Fudan University | 2021-03-17 |
| Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer (NCT04743102) | Beijing Chao Yang Hospital | 2021-01-01 |
| TWICE-IRI: Optimization of Second-line Therapy With Aflibercept, Irinotecan (Day 1 or Day 1,3), 5-Fluorouracile and Folinic Acid in Patients With Metastatic Colorectal Cancer. A Randomized Phase III Study. (NCT04392479) | Hôpital Franco-Britannique-Fondation Cognacq-Jay | 2020-09-02 |
| Prostate Specific Membrane Antigen PET/CT Imaging in PSMA-Related Disease Patients (NCT06690970) | Tianjin Medical University | 2020-09-01 |
| 68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer (NCT04525612) | First Affiliated Hospital of Fujian Medical University | 2020-08-21 |
| 68Ga-FAPI PET/CT in Patients With Various Types of Cancer (NCT04499365) | First Affiliated Hospital of Fujian Medical University | 2020-08-15 |
| Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE (NCT04720768) | Peter MacCallum Cancer Centre, Australia | 2020-06-04 |
| SBRT for Oligo-metastatic Lesions After Systemic Treatment of Primary Metastatic Nasopharyngeal Carcinoma (NCT04351282) | Fudan University | 2020-06-01 |
| Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients (NCT04261777) | Saving Patients' Lives Medical B.V. | 2020-05-27 |
| Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma (NCT04472403) | Sun Yat-sen University | 2019-11-26 |
| Comparison of FDG and FAPI in Patients With Various Types of Cancer (NCT04416165) | The First Affiliated Hospital of Xiamen University | 2019-10-20 |
| Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC) (NCT03909724) | Amsterdam UMC, location VUmc | 2019-10-01 |
| Percutaneous Vertebroplasty Using Rotary Cutter for Bone Metastases (NCT04017728) | Li Min | 2019-07-30 |
| Palliative Radiation Oncology Chief's Clinic (NCT03995927) | Wake Forest University Health Sciences | 2019-07-15 |
| A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101) (NCT04009681) | Synthorx, Inc, a Sanofi company | 2019-06-20 |
| Same-session MR-only Simulation and Treatment With MRI-guided Adaptive Palliative RadioTherapy (NCT03824366) | Washington University School of Medicine | 2019-04-23 |
| Study of Neoadjuvant Regimen for Radioactive Iodine Treatment of Metastatic and Advanced Differentiated Thyroid Cancers (NCT04180007) | Nanjing First Hospital, Nanjing Medical University | 2019-04-10 |
| Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer (NCT03913182) | Shanghai Chest Hospital | 2019-04-02 |
| Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma (NCT03799744) | Institut Català d'Oncologia | 2019-03-20 |
| Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas (NCT03783936) | Ashwin Somasundaram | 2019-01-24 |
| Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway (NCT03652493) | Centre Francois Baclesse | 2018-09-10 |
| Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients. (NCT03644303) | Royal Marsden NHS Foundation Trust | 2018-08-13 |
| A Biomarker Study of Palbociclib + Fulvestrant for Second, and Third Line of Postmenopausal Women With hr+/her2- Advanced Breast Cancer (NCT03560856) | Assistance Publique - Hôpitaux de Paris | 2018-06-27 |
| Dose-escalation Study of IMC-001 in Subject With Metastatic or Locally-advanced Solid Tumors (NCT03644056) | ImmuneOncia Therapeutics Inc. | 2018-03-22 |
| Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer (NCT03927287) | Rabin Medical Center | 2018-01-01 |
| Role of CTC´s Spread During Pancreaticoduodenectomy in Patients With Pancreatic and Periampullary Tumors (NCT03340844) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2017-12-15 |
| Kypho-IORT vs. EBRT in Spinal Metastases (NCT02773966) | Universitätsmedizin Mannheim | 2017-11-12 |
| Pembrolizumab + Idelalisib for Lung Cancer Study (NCT03257722) | Asha Nayak | 2017-09-26 |
| Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel (NCT03295565) | The Netherlands Cancer Institute | 2017-05-07 |
| Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC) (NCT02942238) | Ruijin Hospital | 2017-01-01 |
| Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma) (NCT03230201) | Peking University First Hospital | 2017-01-01 |
| A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine (NCT02915744) | Nektar Therapeutics | 2016-11-01 |
| Clinical Relevance of NGS Analysis for High-purity CTC From Cancer Patients With Disruptive Gene Mutation(s) (NCT03002350) | Chang Gung Memorial Hospital | 2016-08-01 |
| 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases (NCT02721433) | Ottawa Hospital Research Institute | 2016-08-01 |
| Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy (NCT02711007) | GUO WEI | 2016-03-01 |
| A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors (NCT02743637) | SynDevRx, Inc. | 2016-02-01 |
| Liver Transplantation in Patients With Unresectable Colorectal Liver Metastases Treated by Chemotherapy (NCT02597348) | Assistance Publique - Hôpitaux de Paris | 2016-02-01 |
| Integrative Analysis of CRC Liver Metastasis (NCT02917707) | Da Fu | 2016-01-01 |
| Perioperative Chemotherapy Plus Cetuximab Versus Chemotherapy Alone for High Risk Resectable Colorectal Liver Metastasis (NCT03031444) | Peking University Cancer Hospital & Institute | 2016-01-01 |
| The Clinical Relevance of P16 Expressing CTCs Detection Comparing With HPV Infection in Cancer Tissue in HNSCC Patients. (NCT02791607) | Chang Gung Memorial Hospital | 2015-07-01 |
| Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis (NCT02443103) | Kathy Miller | 2015-05-07 |
| Study of Radiation Therapy in Combination With Xeloda, for Initially Metastatic, Low and Middle Rectal Cancer (NCT03634202) | Institut Cancerologie de l'Ouest | 2015-05-05 |
| A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer (NCT02402972) | Xu jianmin | 2015-02-01 |
| The Clinical Relevance of Immune Cells and CTC in HNSCC Patients (NCT02420600) | Chang Gung Memorial Hospital | 2015-01-01 |
| Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study) (NCT02311205) | Asan Medical Center | 2014-12-01 |
| Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy (NCT02317393) | Centre Francois Baclesse | 2014-12-01 |
| Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer Patients (NCT02251353) | Federation of Breast Diseases Societies | 2014-06-01 |
| Radiofrequency Ablation Using Cooled-Wet Electrode (NCT02675894) | Seoul National University Hospital | 2014-04-14 |
| Salvage Surgery for Patients With Metastatic GIST With Rego (NCT04343456) | Chang Gung Memorial Hospital | 2014-01-01 |
| Monopolar Radiofrequency Ablation Using a Dual Switching System and a Separable Clustered Electrode (Octopus®) (NCT02675881) | Seoul National University Hospital | 2013-08-05 |
| Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment (NCT02061085) | MedSIR | 2013-07-01 |
| Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma (NCT01935700) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2013-06-06 |
| Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery (NCT01798771) | Johann Wolfgang Goethe University Hospital | 2013-03-01 |
| Utility and Cost-effectiveness of Microscopic Examination of the Neck Dissection. (NCT03237195) | University of Mississippi Medical Center | 2013-01-01 |
| Sentinel Lymph Node (SLN) in Colorectal Carcinoma (CRC) With a Near-infrared (NIR)-Dye (NCT02122523) | Amsterdam UMC, location VUmc | 2013-01-01 |
| Prognostic Value of CTC in HNSCC Patients (NCT01884129) | Chang Gung Memorial Hospital | 2012-06-01 |
| Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis (NCT03518502) | Korea University | 2012-03-01 |
| Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer (NCT01490996) | University of Leicester | 2012-02-01 |
| Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer (NCT01460186) | Centre Leon Berard | 2011-12-01 |
| Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies (NCT02683538) | Seoul National University Hospital | 2011-11-01 |
| A Trial of Glutamine to Prevent Oxaliplatin Neurotoxicity and a Pharmacokinetic Analysis of Oxaliplatin (NCT01157039) | AHS Cancer Control Alberta | 2011-10-01 |
| ECI301 and Radiation for Advanced or Metastatic Cancer (NCT01441115) | National Cancer Institute (NCI) | 2011-09-06 |
| Health Related Quality of Life After Surgery and Oncological Treatment of Colorectal Liver Metastases (NCT01587976) | Haukeland University Hospital | 2011-06-01 |
| Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin (NCT02087475) | Sixth Affiliated Hospital, Sun Yat-sen University | 2011-01-01 |
| Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors (NCT01199822) | Eli Lilly and Company | 2010-09-01 |
| Neo-adjuvant Peptide Receptor Mediated Radiotherapy With 177Lutetium in Front of Curative Intended Liver Transplantation in Patients With Hepatic Metastasis of Neuroendocrine Tumors (NEO-LEBE) (NCT01201096) | University of Jena | 2010-09-01 |
| FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer (NCT01206530) | Abramson Cancer Center at Penn Medicine | 2010-09-01 |
| Targeted Therapy Selection Based on Tumor Tissue Kinase Activity Profiles for Patients With Advanced Solid Malignancies, an Exploratory Study (NCT01190241) | Amsterdam UMC, location VUmc | 2010-08-01 |
| Exclusive Hypofractionated Stereotactic Radiotherapy in Non-resectable Single Brain Metastasis (NCT01169116) | Barretos Cancer Hospital | 2010-07-01 |
| PET-CT and Circulating Tumor Cells in Colorectal Cancer (NCT01163305) | Chinese University of Hong Kong | 2010-06-30 |
| Exploration of Circulating VE-cadherin in Metastatic Colorectal Adenocarcinoma Patients Treated With Bevacizumab (NCT01405430) | Centre Leon Berard | 2010-05-01 |
| A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer (NCT01000948) | Aarhus University Hospital | 2009-10-01 |
| Window Study of ZD4054 in Metastatic Prostate Cancer (NCT01168141) | The Christie NHS Foundation Trust | 2009-07-01 |
| Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC) (NCT01069770) | Korean Urological Oncology Society | 2009-07-01 |
| Placebo-controlled Evaluation of Ropivacaine Efficacy by Local Infiltrations (NCT01194843) | Centre Leon Berard | 2009-03-01 |
| Gene-expression Profiles in CNS-metastatic Non-small Cell Lung Cancer (NCT00862173) | National Institute of Cancerología | 2008-03-01 |
| TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention (NCT01613482) | Centre Oscar Lambret | 2008-01-01 |
| First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy (NCT00389155) | Bristol-Myers Squibb | 2007-01-01 |
| A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer (NCT00371254) | Bristol-Myers Squibb | 2006-12-01 |
| Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer (NCT00371345) | Bristol-Myers Squibb | 2006-12-01 |